Silk Road Medical Inc (SILK) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 550 transactions totaling $978.2M, demonstrating a bearish sentiment with -$977.6M in net insider flow. The most recent transaction on Sep 17, 2024 involved a transaction of 1,299,042 shares valued at $0.
No significant insider buying has been recorded for SILK in the recent period.
No significant insider selling has been recorded for SILK in the recent period.
Based on recent SEC filings, insider sentiment for SILK is bearish with an Insider Alignment Score of 0/100 and a net flow of -$977.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Silk Road Medical Inc (SILK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading SILK stock, having executed 550 transactions in the past 90 days. The most active insider is Joseph P. Landy (Executive), who has made 3 transactions totaling $241.8M.
Get notified when executives and directors at SILK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | Mckhann Chas | Executive | Award | 1,299,042 | $N/A | $0 | |
| Sep 17, 2024 | Mckhann Chas | Executive | Disposition | 1,299,042 | $N/A | $0 | |
| Sep 17, 2024 | Mckhann Chas | Executive | Disposition | 722,396 | $N/A | $0 | |
| Sep 17, 2024 | W. Buchanan Lucas | Executive | Award | 50,876 | $N/A | $0 | |
| Sep 17, 2024 | W. Buchanan Lucas | Executive | Disposition | 50,876 | $N/A | $0 | |
| Sep 17, 2024 | W. Buchanan Lucas | Executive | Disposition | 13,518 | $N/A | $0 | |
| Sep 17, 2024 | W. Buchanan Lucas | Executive | Disposition | 503,295 | $N/A | $0 | |
| Sep 17, 2024 | S. Davis Andrew | Executive | Disposition | 42,218 | $N/A | $0 | |
| Sep 17, 2024 | S. Davis Andrew | Executive | Award | 42,218 | $N/A | $0 | |
| Sep 17, 2024 | S. Davis Andrew | Executive | Disposition | 290,077 | $N/A | $0 | |
| Sep 17, 2024 | M. Klemz Kevin | Executive | Award | 29,062 | $N/A | $0 | |
| Sep 17, 2024 | M. Klemz Kevin | Executive | Disposition | 29,062 | $N/A | $0 | |
| Sep 17, 2024 | M. Klemz Kevin | Executive | Disposition | 162,926 | $N/A | $0 | |
| Sep 17, 2024 | L. Jones Marie | Executive | Disposition | 79,266 | $N/A | $0 | |
| Sep 17, 2024 | Ruedy Richard | Executive | Award | 26,250 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 209 | $977.9M | 99.2% |
Exercise(M) | 174 | $4.9M | 0.5% |
Disposition(D) | 21 | $1.6M | 0.2% |
Payment(F) | 16 | $1.1M | 0.1% |
Purchase(P) | 2 | $302.0K | 0.0% |
Award(A) | 93 | $285.9K | 0.0% |
Exercise (Options)(X) | 1 | $31.1K | 0.0% |
Other(J) | 22 | $0 | 0.0% |
Conversion(C) | 12 | $0 | 0.0% |
Insider selling pressure at Silk Road Medical Inc has increased, with 26 insiders executing 550 transactions across all time. Total sales of $977.9M significantly outpace purchases of $302.0K, resulting in a net outflow of $977.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.